Key Personnel
Mya Thomae, RAC, CQA
Mya has almost 20 years of experience with regulatory and quality, much of it as a consultant. Prior to becoming a consultant, Mya learned the ropes at Chiron and OraSure....Leonard Buchner
Leonard has more than 30 years of experience in the IVD industry and posseses industry-leading expertise applying biostatistics to analytic studies and clinical trial design. Leonard has extensive experience building,...Barbara Elashoff, MS
Barbara has more than 15 years of experience as a biostatistician, including five years as a statistical reviewer at FDA. Barbara comes to Myraqa from a ten-year career as an...Jo-Ann Gonzales, RAC
Jo-Ann has over 12 years of regulatory experience, 10 of which have been specifically with IVDs. She comes to Myraqa having served in regulatory for four years at Novartis and...Lorry Huffman, RAC, MBA, MT
Lorry has more than 20 years of experience managing regulatory affairs in both the device and pharma industries. Lorry has built and supervised RA/QA departments and led regulatory efforts in...David Kern, RAC, MBA
Dave has more than 20 years of experience developing IVD and life science products. His experience in product development, project management, business development and relationship management grants him a wide...Claudia Koontz
Claudia has a diverse array of experiences supervising projects, resources, communications and accounting functions in a variety of industries. Over 15+ years, Claudia has played key roles in clinical, telecommunications,...Tina M. Landess, CCRA
Tina has more than 12 years of experience with clinical trials as both a consultant and permanent employee of Roche Molecular Systems, BioMedicines, Bayer Diagnostics, Chiron and most recently, Vermillion....Maureen Mende, RAC, MBA
Maureen has over 25 years of experience in the regulatory and quality arenas, including 16 years specifically in IVD regulatory. She comes to Myraqa from two years at Affymetrix, where...Ann Rea, PMP
Ann has more than 10 years of project management experience in the technology and life science industries, with a particular focus on developing, supporting, implementing and managing software projects. Ann...Gene Redig, CQA, CSQE, CQM
Gene has more than 25 years of experience in many facets of R&D, quality and regulatory. He has spent most of the last ten years working specifically in medical devices...Mark M. Sweeny, MA
Mark Sweeny was a key player in the regulatory, quality and compliance function at Applied Biosystems from 1990 until he joined Myraqa in 2008. During his time at AB, Mark...Cindy Van Duker, RAC
Cindy has more than 10 years of experience managing regulatory affairs for IVD and medical device products. She comes to Myraqa from Volcano Corporation, where she served as Manager of...Mamta Vats
Mamta has more than four years of experience with regulatory affairs in the medical device industry. In addition to her experience working with FDA, Mamta has experience with BSI, Health...Diane M. Ward, PhD
Diane Ward is an immunologist with over 20 years of experience in the diagnostic industy and has a comprehensive track record in new product development. With particular expertise in systems...Jack Ward, CQM, CSQE
Jack Ward has more than 25 years of experience working with quality, compliance and R&D at a wide range of medical device companies. Jack spent more than 10 years in...Bryan Hardester
Bryan is an accomplished musician who became a top performer at his "day job" by bringing an artistic level of discipline and dedication to everything he does. Bryan has managed...Dave Moore
Dave Moore comes to Myraqa from Adobe Systems, where he was a Volume Licensing Manager. Dave has had management positions in software, marketing, retail and nonprofits. Although he is new...Dylan Reinhardt
Dylan comes to Myraqa from a career in computer programming, IT management and corporate communications. In 2000, Dylan helped Mya set up her first web site and has been involved...Recent Blogs
Great New Companion Diagnostics E-Book Released Today
A valuable resource in a hot, but under-informed segment of the market
Oragene Clearance Shows DNA Stabilization is Class II
Clearance could have a significant impact on DTCG providers
My Screening Test for Screening Tests
Offering up a rare bit of regulatory certainty
The Abolish OIVD Act of 2011
A torches-and-pitchforks approach to LDT regulations

















